טוען...
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
We studied 97 patients who developed cytomegalovirus (CMV) viremia following an allogeneic hemopoietic stem cell transplant (HSCT) between 2010 and 2015, treated with foscarnet, with the aim of assessing efficacy and safety. The donor was unrelated in 30 patients (UD) and a family HLA-haploidentical...
שמור ב:
| הוצא לאור ב: | Bone Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group UK
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6281566/ https://ncbi.nlm.nih.gov/pubmed/29795416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0200-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|